Surface Modification of Polymeric Nanoparticles with M2pep Peptide for Drug Delivery to Tumor-Associated Macrophages
Tumor-associated macrophages (TAMs) with immune-suppressive M2-like phenotype constitute a significant part of tumor and support its growth, thus making an attractive therapeutic target for cancer therapy. To improve the delivery of drugs that control the survival and/or functions of TAMs, we developed nanoparticulate drug carriers with high affinity for TAMs.
Poly(lactic-co-glycolic acid) nanoparticles were coated with M2pep, a peptide ligand selectively binding to M2-polarized macrophages, via a simple surface modification method based on tannic acid-iron complex. The interactions of M2pep-coated nanoparticles with macrophages of different phenotypes were tested in vitro and in vivo. PLX3397, an inhibitor of the colony stimulating factor-1 (CSF-1)/CSF-1 receptor (CSF-1R) pathway and macrophage survival, was delivered to B16F10 tumors via M2pep-modified PLGA nanoparticles.
In bone marrow-derived macrophages polarized to M2 phenotype, M2pep-coated nanoparticles showed greater cellular uptake than those without M2pep. Consistently, M2pep-coated nanoparticles showed relatively high localization of CD206+ macrophages in B16F10 tumors. PLX3397 encapsulated in M2pep-coated nanoparticles attenuated tumor growth better than the free drug counterpart.
These results support that M2pep-coating can help nanoparticles to interact with M2-like TAMs and facilitate the delivery of drugs that control the tumor-supportive functions of TAMs.
KEY WORDSDrug delivery M2pep PLGA nanoparticles PLX3397 tumor-associated macrophages
Acknowledgments and Disclosures
This work was supported by NIH R01 EB017791, NIH R01 CA232419, and the fellowship support from the China Scholarship Council Fellowship to L.P.
- 9.Sawawejksza K, Kandeferszerszeń M. Tumor-associated macrophages as target for antitumor therapy. Arch Immunol Ther Ex. 2018;66(2):97–111.Google Scholar
- 10.Mantovani A, Schioppa T, Porta C, Allavena P, Sica A. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metast Rev. 2006;25(3):315–22.Google Scholar
- 19.Maryelise C, Jingjing T, Yu JL, Hua C, Maja Z, Koka M, et al. Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival. Proc Natl Acad Sci U S A. 2013;110(40):15919–24.Google Scholar
- 26.Hong S, Yeom J, Song IT, Kang SM, Lee H, Lee H. Pyrogallol 2-Aminoethane: a plant flavonoid-inspired molecule for material-independent surface chemistry. Adv Mater Interfaces. 2014;1:1400113.Google Scholar
- 29.Shin M, Lee HA, Lee M, Shin Y, Song JJ, Kang SW, et al. Targeting protein and peptide therapeutics to the heart via tannic acid modification. Nat Biomed Eng. 2018;2(5):304–17.Google Scholar
- 36.Zhao P, Yin W, Wu A, Tang Y, Wang J, Pan Z, et al. Dual-targeting to Cancer cells and M2 macrophages via biomimetic delivery of Mannosylated albumin nanoparticles for drug-resistant Cancer therapy. Adv Funct Mater. 2017;27(44):1700403.Google Scholar